Stock Track | Immatics N.V. Soars 5.80% After-Hours on Goldman Sachs Analyst Upgrade and $13.50 Price Target

Stock Track

2024/11/26

Immatics N.V. (IMTX) stock surged 5.80% in after-hours trading on Monday, following an analyst upgrade from Goldman Sachs. Analyst Rajan Sharma initiated coverage on Immatics with a Buy rating and set a price target of $13.50 per share, implying significant upside from current levels.

Sharma cited Immatics' promising pipeline of immunotherapies and innovative technologies as key reasons for the bullish outlook. The analyst believes the company's ACTengine platform could drive success in developing novel treatments for solid tumors, a major unmet medical need.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1135654649"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135654649\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135654649?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-26 07:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135654649","market":"us","top_or_hot":-1,"title":"Stock Track | Immatics N.V. Soars 5.80% After-Hours on Goldman Sachs Analyst Upgrade and $13.50 Price Target","media":"Stock Track","content":"<p>Immatics N.V. (IMTX) stock surged 5.80% in after-hours trading on Monday, following an analyst upgrade from Goldman Sachs. Analyst Rajan Sharma initiated coverage on Immatics with a Buy rating and set a price target of $13.50 per share, implying significant upside from current levels.</p>\n\n<p>Sharma cited Immatics' promising pipeline of immunotherapies and innovative technologies as key reasons for the bullish outlook. The analyst believes the company's ACTengine platform could drive success in developing novel treatments for solid tumors, a major unmet medical need.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Immatics N.V. Soars 5.80% After-Hours on Goldman Sachs Analyst Upgrade and $13.50 Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Immatics N.V. Soars 5.80% After-Hours on Goldman Sachs Analyst Upgrade and $13.50 Price Target\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-11-26 07:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Immatics N.V. (IMTX) stock surged 5.80% in after-hours trading on Monday, following an analyst upgrade from Goldman Sachs. Analyst Rajan Sharma initiated coverage on Immatics with a Buy rating and set a price target of $13.50 per share, implying significant upside from current levels.</p>\n\n<p>Sharma cited Immatics' promising pipeline of immunotherapies and innovative technologies as key reasons for the bullish outlook. The analyst believes the company's ACTengine platform could drive success in developing novel treatments for solid tumors, a major unmet medical need.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMTX","symbol_name":"Immatics N.V.","start_time":0,"source_url":"","article_id":"1135654649","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135654649","pubTimestamp":1732577420,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Immatics N.V.  stock surged 5.80% in after-hours trading on Monday, following an analyst upgrade from Goldman Sachs. Analyst Rajan Sharma initiated coverage on Immatics with a Buy rating and set a price target of $13.50 per share, implying significant upside from current levels.Sharma cited Immatics' promising pipeline of immunotherapies and innovative technologies as key reasons for the bullish outlook. The analyst believes the company's ACTengine platform could drive success in developing nove","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IMTX":"Immatics N.V."},"translate_title":"高盛分析师上调评级，目标价13.50美元，股价盘后飙升5.80%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMTX":1},"content_text":"Immatics N.V. (IMTX) stock surged 5.80% in after-hours trading on Monday, following an analyst upgrade from Goldman Sachs. Analyst Rajan Sharma initiated coverage on Immatics with a Buy rating and set a price target of $13.50 per share, implying significant upside from current levels.\nSharma cited Immatics' promising pipeline of immunotherapies and innovative technologies as key reasons for the bullish outlook. The analyst believes the company's ACTengine platform could drive success in developing novel treatments for solid tumors, a major unmet medical need.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}